Skip to main content
Signal8

McGrath Lynne Fahey

SEC insider (Form 3/4/5 filer). CIK 0001866270. Director at Alzamend Neuro, Inc. (ALZN). 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 23, 2025. Located in ATLANTA, GA.

Companies McGrath Lynne Fahey has filed insider reports for

  • Alzamend Neuro, Inc. (ALZN): Director
McGrath Lynne Fahey profile photo

McGrath Lynne Fahey

CIK: 0001866270

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Alzamend Neuro, Inc. logo
ALZN

Alzamend Neuro, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Alzamend Neuro, Inc. logo
    ALZN

    Alzamend Neuro, Inc.

    Oct 23, 2025
    Sale
    Direct
    30 shares at avg. $2.29$68.7

1-1 of 1